InvestorsHub Logo
Followers 13
Posts 697
Boards Moderated 0
Alias Born 01/12/2013

Re: None

Sunday, 12/28/2014 7:42:43 AM

Sunday, December 28, 2014 7:42:43 AM

Post# of 130503
Maxim Group conversation:

I spoke to an Analyst at one of the leading investment boutique firms in NYC (who covers small bio's). He routinely speaks to Gerald from time to time; he reminded me that the ESS trial start up has unique attributes because its not a drug compound that carries a lot of risk. Most importantly, he said once the trial starts up; the market cap alone should be increased by at least $150-$180mm (and Wall street will heed notice once the firm is Up listed).

Overall, the incremental dilution (more recent) is minor in relation to the quality assets that Gerald (and management) have been acquiring lately and of whats most important is the true underlying valuation (so watch what happens to the Market cap in 2015....you will be pleasantly surprised).

Note: Sorry Solantey; you last chance to acquire the PPS much cheaper are behind you. Just recognize that you cant stop a tidal wave that's starting to begin and in motion; just jump on and go for the ride.